IP Verse

Graf Von Stosch, Andreas Analysis

LAW FIRM ANALYSIS

Latest European patent oppositions filed by Graf Von Stosch, Andreas

Patent:
EP3202371
Title:
Heart Valve Anchoring Device
Applicant:
TRICARES
Opposition Date:
2021-09-15
Patent:
EP2714071
Title:
Individualized Vaccines For Cancer
Applicant:
BIONTECH AG
Opposition Date:
2020-04-14
Patent:
EP2911684
Title:
Il-15R Alpha Forms, Cells Expressing Il-15R Alpha Forms, And Therapeutic Uses Of Il-15R Alpha And Il-15/Il-15R Alpha Complexes
Applicant:
ADMUNE THERAPEUTICS LLC
Opposition Date:
2020-03-19
Patent:
EP3060303
Title:
Mrna Therapy For Argininosuccinate Synthetase Deficiency
Applicant:
TRANSLATE BIO, INC.
Opposition Date:
2019-08-14
Patent:
EP2563906
Title:
Improved Cell Cultivation Process
Applicant:
NOVARTIS AG
Opposition Date:
2018-08-07
Patent:
EP2056845
Title:
Structure And Use Of 5' Phosphate Oligonucleotides
Applicant:
HARTMANN, GUNTHER
Opposition Date:
2018-07-11
Patent:
EP2637670
Title:
Prevention Of Adverse Effects Caused By Cd3 Specific Binding Domains
Applicant:
AMGEN RESEARCH (MUNICH) GMBH
Opposition Date:
2017-12-07

Top clients of Graf Von Stosch, Andreas filing patent oppositions

Company:
WITHERS & ROGERS LLP
Count:
3
Company:
GRAF VON STOSCH, ANDREAS
Count:
2
Company:
LINDIS BIOTECH GMBH
Count:
1
Company:
STRAWMAN LIMITED
Count:
1
Company:
T-HEART SAS
Count:
1